Close
Achema middle east
swop processing & packaging

Clinical Trials

CytoDyn and AEIH to begin trials of leronlimab in severe Covid-19

This development is part of CytoDyn’s agreement to collaborate with AEIH to carry out the trials in up to 45 clinical sites in the country. These...

Eiger to add Peginterferon Lambda to Covid-19 trial in Brazil

Eiger BioPharmaceuticals has said that its investigational agent, Peginterferon Lambda, will be added to the Phase III TOGETHER platform study of Covid-19 outpatients in Brazil. A...

Moderna Announces Positive Initial Booster Data Against SARS-CoV-2 Variants of Concern

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced initial data from its Phase 2 study showing that a single 50...

Vaxart Oral COVID-19 Vaccine Phase I Study Suggests Broad Cross-Reactivity against Other Coronaviruses

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced at Vaxart’s key opinion leader...

Kintor Pharmaceuticals Announces Successful Proxalutamide COVID-19 Phase III Clinical Trial Initiation and Patient Dosing in U.S.

Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the phase III clinical trial of proxalutamide for the...

Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization

Thermo Fisher Scientific Inc., the world leader in serving science, and PPD, Inc., a leading global provider of clinical research services to the pharma and...

Moderna Provides Clinical and Supply Updates on COVID-19 Vaccine Program Ahead of 2nd Annual Vaccines Day

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced clinical and supply updates on its COVID-19 Vaccine program. New results from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »